172 related articles for article (PubMed ID: 9754702)
1. Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?
Schwarz J; Scherer J; Trenkwalder C; Mozley PD; Tatsch K
Psychiatry Res; 1998 Jul; 83(1):23-8. PubMed ID: 9754702
[TBL] [Abstract][Full Text] [Related]
2. Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years.
Chouker M; Tatsch K; Linke R; Pogarell O; Hahn K; Schwarz J
Nucl Med Commun; 2001 Jun; 22(6):721-5. PubMed ID: 11403185
[TBL] [Abstract][Full Text] [Related]
3. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.
Tatsch K; Schwarz J; Mozley PD; Linke R; Pogarell O; Oertel WH; Fieber RS; Hahn K; Kung HF
Eur J Nucl Med; 1997 Apr; 24(4):415-21. PubMed ID: 9096093
[TBL] [Abstract][Full Text] [Related]
4. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.
Booij J; Tissingh G; Boer GJ; Speelman JD; Stoof JC; Janssen AG; Wolters EC; van Royen EA
J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):133-40. PubMed ID: 9048712
[TBL] [Abstract][Full Text] [Related]
5. Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease: implications for a preclinical diagnosis.
Schwarz J; Linke R; Kerner M; Mozley PD; Trenkwalder C; Gasser T; Tatsch K
Arch Neurol; 2000 Feb; 57(2):205-8. PubMed ID: 10681078
[TBL] [Abstract][Full Text] [Related]
6. Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease: analysis with [(123)I]IPT single photon emission computed tomography.
Im JH; Chung SJ; Kim JS; Lee MC
J Neurol Sci; 2006 May; 244(1-2):103-9. PubMed ID: 16473371
[TBL] [Abstract][Full Text] [Related]
7. Comparison of alpha-dihydroergocryptine and levodopa monotherapy in Parkinson's disease: assessment of changes in DAT binding with [123I]IPT SPECT.
Pöpperl G; Tatsch K; Ruzicka E; Storch A; Gasser T; Schwarz J
J Neural Transm (Vienna); 2004 Aug; 111(8):1041-52. PubMed ID: 15254792
[TBL] [Abstract][Full Text] [Related]
8. SPECT imaging of the dopamine transporter with [(123)I]-beta-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction.
Sakakibara R; Shinotoh H; Uchiyama T; Yoshiyama M; Hattori T; Yamanishi T
J Neurol Sci; 2001 Jun; 187(1-2):55-9. PubMed ID: 11440745
[TBL] [Abstract][Full Text] [Related]
9. Imaging and quantitation of dopamine transporters with iodine-123-IPT in normal and Parkinson's disease subjects.
Kim HJ; Im JH; Yang SO; Moon DH; Ryu JS; Bong JK; Nam KP; Cheon JH; Lee MC; Lee HK
J Nucl Med; 1997 Nov; 38(11):1703-11. PubMed ID: 9374337
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
11. [123I]IPT binding to the presynaptic dopamine transporter: variation of intra- and interobserver data evaluation in parkinsonian patients and controls.
Linke R; Gostomzyk J; Hahn K; Tatsch K
Eur J Nucl Med; 2000 Dec; 27(12):1809-12. PubMed ID: 11189944
[TBL] [Abstract][Full Text] [Related]
12. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism.
Booij J; Speelman JD; Horstink MW; Wolters EC
Eur J Nucl Med; 2001 Mar; 28(3):266-72. PubMed ID: 11315592
[TBL] [Abstract][Full Text] [Related]
13. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.
Eisensehr I; Linke R; Noachtar S; Schwarz J; Gildehaus FJ; Tatsch K
Brain; 2000 Jun; 123 ( Pt 6)():1155-60. PubMed ID: 10825354
[TBL] [Abstract][Full Text] [Related]
14. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease.
Leenders KL; Salmon EP; Tyrrell P; Perani D; Brooks DJ; Sager H; Jones T; Marsden CD; Frackowiak RS
Arch Neurol; 1990 Dec; 47(12):1290-8. PubMed ID: 2123623
[TBL] [Abstract][Full Text] [Related]
15. Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.
Mozley PD; Kim HJ; Gur RC; Tatsch K; Muenz LR; McElgin WT; Kung MP; Mu M; Myers AM; Kung HF
J Nucl Med; 1996 Dec; 37(12):1965-70. PubMed ID: 8970515
[TBL] [Abstract][Full Text] [Related]
16. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FPCIT SPECT.
Booij J; Hemelaar TG; Speelman JD; de Bruin K; Janssen AG; van Royen EA
J Nucl Med; 1999 May; 40(5):753-61. PubMed ID: 10319746
[TBL] [Abstract][Full Text] [Related]
17. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease.
Lorberboym M; Treves TA; Melamed E; Lampl Y; Hellmann M; Djaldetti R
Mov Disord; 2006 Apr; 21(4):510-4. PubMed ID: 16250023
[TBL] [Abstract][Full Text] [Related]
18. [Striatal dopamine transporter density decrease in first episode schizophrenic patients treated with risperidone].
Mateos JJ; Lomeña F; Parellada E; Font M; Fernández E; Pavia J; Prats A; Bernardo M
Rev Esp Med Nucl; 2006; 25(3):159-65. PubMed ID: 16762269
[TBL] [Abstract][Full Text] [Related]
19. Decreased striatal dopamine transporter binding assessed with [123I] FP-CIT in first-episode schizophrenic patients with and without short-term antipsychotic-induced parkinsonism.
Mateos JJ; Lomeña F; Parellada E; Font M; Fernandez E; Pavia J; Prats A; Pons F; Bernardo M
Psychopharmacology (Berl); 2005 Sep; 181(2):401-6. PubMed ID: 15830229
[TBL] [Abstract][Full Text] [Related]
20. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
